DFE Pharma: Martti Hedman, CEO
Excipients specialist DFE Pharma has named Martti Hedman CEO. He replaces former CEO Bas van Driel, who stepped down in February.
On behalf of the company’s governance board, Herman Ermens of Royal FrieslandCampina said, “Martti will bring a wealth of international experience in the pharma industry as well as a broad range of both industry and customer relationships. We are confident that Martti is very well-placed to take the business to the next level as a global excipient company.”